Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel vs Adjusted Clopidogrel in ACS Patients with HPR
NCT01493999Phase 4Completed
- Sponsor
- University of Pécs
- Start
- Sep 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prasugrel in acute coronary syndrome (ACS) (2 arms), sponsored by University of Pécs. Primary endpoint: Platelet reactivity measured with Multiplate at 4 days. Started Sep 2011; status: completed.
02
Drugs
prasugrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01493999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01493999.